Quest Diagnostics' consistent ROCE and increased capital employed over the past five years suggest steady reinvestment at good returns. This trend, reflected in the stock's strong performance, is expected to continue.
The acquisition aligns with Quest's strategy to grow through accretive outreach laboratory acquisitions and expands its ability to serve providers and patients in Ohio and Pennsylvania.
The CEO of Quest Diagnostics, Jim Davis, believes Yuri Fesko's deep medical expertise and patient-care advocacy will greatly contribute to the company's strategic decisions. His appointment especially bolsters Quest's efforts to improve customer experiences via diagnostic innovations.
Quest Diagnostics shows favorable metrics with robust reinvestment strategies. Significant earnings growth and an anticipated rise in future ROE, despite a higher payout ratio, hint at other growth factors.
Since he will be retiring, I wanted to highlight his unusual trading while in Congress for 40 years. He became a millionaire many times over on a modest federal salary from trading. Take a look: Thomas Carper bought 30k in$做空纳斯达克100指数ETF-ProShares(PSQ.US)$, an ultrashort$纳指100ETF-Invesco QQQ Trust(QQQ.US)$index, on July 13 2023. He hedged/shorted in the past with great results with$AdvisorShares主动股票做空ETF(HDGE.US)$, ...
4
6
举报
Jayden Z :
He may have known some non-traditional channel information in advance
Bruski2023ThirtyOne:
It’s really disgusting when you think about it…you’re a career politician with a net worth of 20-30-100mil, some way more. You absolutely have all the insight and information needed for the fuckery
The Covid-19 pandemic isn’t over but the U.S. is already entering a new vaccine boom. But the delayed vaccine rollout continues to raise questions. CNN reports that the U.S. delayed a large-scale vaccine order out of fear of the shots expiring before being administered. Federal agencies are exploring new ways to provide vaccines more efficiently, but the supply shortage poses challenges. For the U.S. government,...
chris from queens :
best comment for anyone reading this they will be pleasantly surprised if they are early to the party.... is a company that is very good in dealing with very infectious diseases and coming up with tests RAPID TEST! DYODD!!! $T2 Biosystems (TTOO.US)$
奎斯特诊疗股票讨论区
Senator Thomas Carper disclosed he profited shorting the US economy.
He became a millionaire many times over on a modest federal salary from trading.
Take a look:
Thomas Carper bought 30k in $做空纳斯达克100指数ETF-ProShares(PSQ.US)$ , an ultrashort $纳指100ETF-Invesco QQQ Trust(QQQ.US)$ index, on July 13 2023.
He hedged/shorted in the past with great results with $AdvisorShares主动股票做空ETF(HDGE.US)$ , ...
2023Q1营收继续下滑10.7%,营业利润大幅下滑40.6%,净利润大幅下滑41.8%。
目前市盈率17.6,市盈率TTM已经提升到20.6,考虑到近期利润大幅萎缩,暂时缺乏吸引力。
The White House is about to turn to vaccine producers to curb the spread of monkeypox
专栏Today's pre-market stock movers: TSLA, T, NOK, UAL and more
In reaction to earnings/guidance:
• $超微电脑(SMCI.US)$ +18%,$诺基亚(NOK.US)$ +7.7%,$丹纳赫(DHR.US)$ +6.3%,$RLI保险(RLI.US)$ +5%,$CSX运输(CSX.US)$ +4.3%,$金沙集团(LVS.US)$ +4.2%,$美国铝业公司(AA.US)$ +3.4%(also authorizes new $500 mln share repurchase program)
• $Steel Dynamics(STLD.US)$ +2.8%,$Herc Holdings(HRI.US)$ +2.6%,$特斯拉(TSLA.US)$ +2.5%, $菲利普莫里斯(PM.US)$ +2.5%,$F.N.B. Corp(FNB.US)$ ...
专栏Today's pre-market stock movers: TWTR, NIU, OCGN, SBUX and more
• $Twitter(已退市)(TWTR.US)$ +20.5% (Elon Musk discloses 9.2% passive stake)
• $康特科技(CAMT.US)$ +9.6%, $Perion Network(PERI.US)$ +6.6% (In reaction to earnings/guidance)
• $小牛电动(NIU.US)$ +5% (reports QI sales volume increased 9.4% yr/yr)
• $Iron Spark I Inc(ISAA.US)$ +3.4% (Hypebeast plans to list on NASDAQ through Merger with Iron Spark I)
• $Gatos Silver(GATO.US)$ +2.3% (Provides Bi-Weekly Status Report)
• $Verve Therapeutics(VERV.US)$ +1.8% (re...
专栏Top upgrades and downgrades on 4/4
• $DCP Midstream(DCP.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $42 (from $36)
• $Leslie's(LESL.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $27 (from $26)
• $罗技(LOGI.US)$ : Goldman Sachs Upgrades to Buy from Neutral
• $蔚来(NIO.US)$ : UBS Upgrades to Buy from Neutral - PT $32 (from $46)
• $Ollie's Bargain Outlet(OLLI.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $65 (from $45)
• $Oric Pharmaceuticals(ORIC.US)$ : Citigro...
暂无评论